Leibniz-Institut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)

The FMP makes contributions of fundamental significance in the field of molecular pharmacology. FMP research focusses on the structures, functions and interactions of proteins and on the development of new concepts for interfering pharmacologically with their functions. This places the research activity of the institute at the forefront of drug development. An interdisciplinary approach is crucial to this type of work, and a particular strength of the FMP is the close interaction in the fields of chemistry and biology. The unique combination of technology platforms at the FMP, including a state-of-art NMR-facility, an open screening platform, and a mass spectrometry lab, provides an ideal environment for research projects that strive to discover new biologically active substances. The institute manages the central screening collection of the ChemBioNet. The institute is a member of the Leibniz-Association and is legally represented by the Forschungsverbund Berlin e.V.